Related Experiment Video
Updated: Aug 19, 2026
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Mesenchymal stem cells in the infarcted heart
Mohit Jain1, Otmar Pfister, Roger J Hajjar
1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02118, USA.
Insights
Mesenchymal stem cells show promise for regenerating heart tissue damaged by myocardial infarction. These cells may help restore cardiac function and treat heart failure by replacing lost cardiomyocytes.
Area of Science:
- Cardiovascular research
- Regenerative medicine
- Stem cell biology
Background:
- Loss of cardiomyocytes leads to cardiac dysfunction and heart failure.
- Myocardial scarring after infarct impairs ventricular function.
- Stem cell therapy is a potential strategy for cardiac repair.
Purpose of the Study:
- To review recent studies on mesenchymal stem cells (MSCs) for cardiac regeneration.
- To explore the therapeutic potential of MSCs in post-myocardial infarct (MI) settings.
Main Methods:
- Literature review of studies using MSCs in cardiac regeneration.
- Analysis of MSC-based therapies for myocardial repair and ventricular dysfunction.
Main Results:
- MSCs are being investigated for their ability to regenerate damaged myocardial tissue.
- Studies explore MSCs for treating conditions following myocardial infarction.
Conclusions:
- Mesenchymal stem cells offer a promising avenue for cardiac regeneration.
- MSC-based therapies are under investigation for treating heart failure post-MI.
Abstract:
A loss of functional cardiomyocytes forms the cellular basis of cardiac dysfunction and heart failure. Stem cell based repletion of scarred myocardial tissue and regeneration of cardiomyocytes have been proposed as a potential treatment of ventricular dysfunction. In this review, we provide an overview of recent studies utilizing mesenchymal stem cells in cardiac regeneration and post-myocardial infarct therapy.
